产品管线

项目
模式
目标
适应症
临床前
早期临床
后期临床
权益
瓴路健坤
管线
OL-101
Autologous
CAR-T
GPRC5D
and BCMA
Multiple
Myeloma
Global
OL-108
Allogeneic
γδ-CAR-T
Undisclosed
Autoimmune
Diseases
Global
Other γδ-CAR-T
Allogeneic
γδ-CAR-T
Undisclosed
Autoimmune
Diseases
Global
Allogene
合作项目
ALLO-316
Allogeneic
CAR-T
CD70
Renal Cell
Carcinoma
Greater
Asia
Other (ALLO-715 / 605 / 819 / 213)
Allogeneic
CAR-T
BCMA, FLT3,
and DLL3
Various
Oncology
Greater
Asia

A GPRC5D and BCMA Bispecific CAR-T Product Demonstrated Dual Antigen Targeting Capability and Efficacy Against Multiple Myeloma Cells Bearing BCMA Mutations Associated with Treatment Resistance

Chang et al. 2024年11月26日

G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D) and B-Cell Maturation Antigen (BCMA) Bi-Specific Dual Chimeric Antigen Receptors (CARs) Effectively Address Antigen Escape and Tumor Heterogeneity Challenge in Multiple Myeloma (MM)

Chang et al., American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting 2024年5月11日

Development of a Novel Allogeneic γδ-T Platform for Off-the-Shelf Adoptive Cell Therapy for Oncology and Autoimmune Diseases

Nanbakhsh et al., American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting 2024年5月10日